Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia
National Cancer Institute (NCI)
Dai Chihara; Evgeny Arons; Maryalice Stetler-Stevenson; Constance M Yuan; Hao-Wei Wang; Hong Zhou; Mark Raffeld; Liqiang Xi; Seth M Steinberg; Julie Feurtado; Lacey James; Wyndham Wilson; Raul C Braylan; Katherine R Calvo; Irina Maric; Alina Dulau-Florea; Robert J Kreitman
Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD.